Wednesday, January 26, 2022 11:15:12 AM
I do know for a fact that they ARE NOT selling shrs to pay for it, but borrowing money would be my guess...
If I had to guess, and this is based upon absolutely nothing but my own gut feeling, I'd say that either the transaction includes an assumption of debt making the purchase price exceptionally low, or that Swahti is selling shares and the proceeds will be used to fund the transaction.
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
